- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07667686
French Validation of the Recovery Assessment Scale (RAS-FR) (VAL-RAS-FR)
Cross-Cultural Adaptation, French Validation, and Development of Derived Versions of the Recovery Assessment Scale (RAS) for the Assessment of Subjective Recovery in Mental Health
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Recovery in mental health extends beyond symptom reduction and includes hope, self-confidence, autonomy, meaning, and continuity of self. As described by Anthony (1993) and further developed through the CHIME framework, recovery is a deeply personal process involving connectedness, hope, identity, meaning, and empowerment. Although French translations of the Recovery Assessment Scale (RAS) have been used previously, no comprehensive psychometric validation of a French version is currently available for routine use in French-speaking psychiatric settings.
VAL-RAS-FR is a monocentric, prospective, observational study designed to cross-culturally adapt, validate, and develop derived versions of the 41-item Recovery Assessment Scale (RAS) for use in French-speaking mental health settings. The study will enroll 260 adult psychiatric patients receiving care at EPSM Metz-Jury, including patients from inpatient units, day hospital settings, community mental health centers (CMP), and EPSIAD follow-up services. Participants will complete self-report questionnaires including the French version of the RAS (RAS-FR), the WHOQOL-BREF, and complementary questionnaires exploring factors associated with subjective recovery. A subgroup of 50 participants will complete the RAS-FR again after one month to assess test-retest reliability.
The study has three complementary objectives. First, it aims to evaluate the psychometric properties of the French version of the RAS, including validity, internal consistency, dimensional structure, and test-retest reliability. Second, it will explore an existential dimension of recovery through the development of the RAS-FR-EX (Existential Extension), an exploratory extension designed to assess aspects such as continuity of self, reconstruction of meaning, and the experience of existing after psychological crisis. Third, it will support the exploratory development of a shorter version of the scale, the RAS-FR-SF (Short Form), intended to facilitate future clinical use while preserving the core dimensions of subjective recovery.
The study does not involve any modification of usual care, invasive procedures, or additional medical examinations. By combining psychometric validation with exploratory clinical development, VAL-RAS-FR aims to provide a validated French-language measure of subjective recovery, improve the assessment of recovery-oriented outcomes in psychiatric care, and contribute to the development of clinically useful tools for French-speaking mental health services.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Audrey WILLIG, Psychologist
- Numéro de téléphone: +33695082545
- E-mail: audrey.willig@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Claire GARIOT, PhD
- Numéro de téléphone: +33387561234
- E-mail: claire.gariot@epsm-metz-jury.fr
Lieux d'étude
-
-
Moselle
-
Jury, Moselle, France, 57245
- Recrutement
- EPSM Metz-Jury
-
Contact:
- Claire GARIOT, Project Manager
- Numéro de téléphone: +33387561234
- E-mail: claire.gariot@epsm-metz-jury.fr
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Adult patient (18 years or older)
- Receiving psychiatric care at EPSM Metz-Jury (inpatient unit, day hospital, community mental health center [CMP], or intensive home-based psychiatric care service [EPSIAD]/post-EPSIAD follow-up)
- Able to understand French
- Able to complete a self-report questionnaire independently or with assistance if needed
- Patients under legal protection measures (guardianship or curatorship) may participate with the agreement of their legal representative, when applicable
Exclusion Criteria:
- Major cognitive impairment
- Severe clinical condition preventing questionnaire completion or understanding of French
- Refusal to participate
- Prisoner or person deprived of liberty by judicial or administrative decision
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Adult psychiatric patients
Adult psychiatric patients receiving care at EPSM Metz-Jury (inpatient units, day hospital, community mental health centers [CMP], and intensive home-based psychiatric care services [EPSIAD]) who are able to complete self-report questionnaires in French.
|
Participants complete self-report questionnaires including the French version of the Recovery Assessment Scale (RAS-FR), the WHOQOL-BREF, and complementary questionnaires related to subjective recovery.
The study also includes the exploratory assessment of six additional existential items.
A subgroup of 50 participants will complete the RAS-FR again after one month to assess test-retest reliability.
No therapeutic intervention, modification of usual care, invasive procedure, or additional medical examination is involved.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Recovery Assessment Scale - French Version (RAS-FR): Total Score, Internal Consistency, Factor Structure, and Test-Retest Reliability
Délai: Baseline and 1 month
|
The Recovery Assessment Scale - French Version (RAS-FR) is a 41-item self-report questionnaire assessing subjective recovery in mental health.
Total scores range from 41 to 205, with higher scores indicating a higher level of subjective recovery.
Psychometric analyses will include internal consistency, dimensional structure, and test-retest reliability.
|
Baseline and 1 month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Correlation between Recovery Assessment Scale - French Version (RAS-FR) and WHOQOL-BREF (World Health Organization Quality of Life - Brief Version) scores
Délai: Baseline
|
Assessment of convergent validity through correlations between the Recovery Assessment Scale - French Version (RAS-FR) total score and WHOQOL-BREF domain scores in adult psychiatric patients, with particular attention to the psychological and social relationship domains.
The RAS-FR total score ranges from 41 to 205, with higher scores indicating a higher level of subjective recovery.
WHOQOL-BREF domain scores range from 0 to 100, with higher scores indicating better perceived quality of life.
Pearson or Spearman correlation coefficients will be calculated.
|
Baseline
|
|
Existential dimension of recovery (RAS-FR-EX) composite score
Délai: Baseline
|
Exploratory assessment of the existential dimension of recovery using six additional items integrated into the French version of the Recovery Assessment Scale (RAS-FR-EX).
A composite score ranging from 6 to 30 will be calculated, with higher scores indicating a stronger endorsement of existential recovery processes.
|
Baseline
|
|
Development of a short-form Recovery Assessment Scale - French Version (RAS-FR-SF)
Délai: Baseline
|
Exploratory item reduction analyses based on responses to the 41-item Recovery Assessment Scale - French Version (RAS-FR).
The objective is to identify a shorter version of the instrument while preserving its psychometric properties and conceptual coverage of subjective recovery.
|
Baseline
|
Collaborateurs et enquêteurs
Collaborateurs
Les enquêteurs
- Chercheur principal: Audrey WILLIG, Psychologist, Clinical Research Unit (URC), EPSM Metz-Jury
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
- qualité de vie
- santé mentale
- résultat rapporté par le patient
- validation psychométrique
- RAS
- rétablissement de la santé mentale
- WHOQOL-BREF
- soins psychiatriques
- adaptation interculturelle
- subjective recovery
- Recovery Assessment Scale
- recovery-oriented care
- existential recovery
- RAS-FR
- French validation
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- EPSM-VAL-RAS-FR
- 2026-A00601-50 (Autre identifiant: ANSM)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .